Juszczyk J, Flieger J, Migdalski P, Skalisz H
Klinika Chorób Zakaznych Akademii Medycznej im., Poznaniu.
Przegl Epidemiol. 1992;46(1-2):11-7.
Fifty eight anti-HCV repeatable positive (the UBI HCV EIA, Microelisa test Organon Teknika) blood donors were tested using LIATEK-HCV EIA (Organon Teknika). The test was constructed using synthetic polypeptides renders possible to conduct separate investigation antibodies against structural and nonstructural antigens of HCV. In 51/58 (88 per cent) cases was agreement of the results with the UBI test, in 3/58 (5.1 per cent) results were negative, and in 4/58 (6.9 per cent) undetermined. In 90 per cent of the seropositive reactivity developed with four to six antigens. The most frequent "serological pattern" was anti: NS4, C1, C2, C3, C4 (31 per cent) and anti: NS4, NS5, C1, C2, C3, C4 (23.5 per cent).
对58名抗丙型肝炎病毒反复呈阳性（使用欧加农公司的UBI HCV EIA微酶免疫检测法）的献血者，采用LIATEK - HCV EIA（欧加农公司）进行检测。该检测采用合成多肽构建，使得能够分别研究针对丙型肝炎病毒结构和非结构抗原的抗体。在51/58（88%）的病例中，结果与UBI检测一致，3/58（5.1%）的结果为阴性，4/58（6.9%）的结果不确定。在90%的血清阳性反应中，有四至六种抗原产生反应。最常见的“血清学模式”是抗：NS4、C1、C2、C3、C4（31%）和抗：NS4、NS5、C1、C2、C3、C4（23.5%）。
